Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-14-052976
Filing Date
2014-08-28
Accepted
2014-08-28 16:05:28
Documents
6
Period of Report
2014-10-13
Effectiveness Date
2014-08-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v387996_def14a.htm DEF 14A 259430
2 GRAPHIC tproxy1.jpg GRAPHIC 5015
3 GRAPHIC tproxy2.jpg GRAPHIC 902
4 GRAPHIC tproxy3.jpg GRAPHIC 1077
5 GRAPHIC tproxy4.jpg GRAPHIC 1064
6 GRAPHIC tproxy5.jpg GRAPHIC 1231
  Complete submission text file 0001144204-14-052976.txt   274295
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

EIN.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 000-17263 | Film No.: 141071869
SIC: 2836 Biological Products, (No Diagnostic Substances)